First Trust Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,307
Closed -$512K 2603
2025
Q2
$512K Sell
17,307
-27,231
-61% -$777K ﹤0.01% 2260
2025
Q1
$1.33M Sell
44,538
-85,153
-66% -$2.6M ﹤0.01% 1941
2024
Q4
$3.72M Sell
129,691
-11,601
-8% -$384K ﹤0.01% 1528
2024
Q3
$5.46M Buy
141,292
+18,321
+15% +$653K 0.01% 1294
2024
Q2
$3.96M Buy
+122,971
New +$4.26M ﹤0.01% 1384
2023
Q3
Sell
-92,793
Closed -$1.99M 2383
2023
Q2
$1.99M Buy
92,793
+3,414
+4% +$77.5K ﹤0.01% 1703
2023
Q1
$2.14M Buy
89,379
+6,814
+8% +$181K ﹤0.01% 1665
2022
Q4
$1.92M Sell
82,565
-7,573
-8% -$153K ﹤0.01% 1714
2022
Q3
$1.44M Buy
90,138
+39,065
+76% +$689K ﹤0.01% 1848
2022
Q2
$905K Sell
51,073
-2,362
-4% -$39.7K ﹤0.01% 2018
2022
Q1
$1.09M Sell
53,435
-3,076
-5% -$58.1K ﹤0.01% 2020
2021
Q4
$1.06M Buy
56,511
+5,841
+12% +$114K ﹤0.01% 2030
2021
Q3
$1M Buy
+50,670
New +$1.1M ﹤0.01% 2037

Other funds holding COLL

First Trust Advisors's COLL Position: Q3 2025 in Review

First Trust Advisors sold out of Collegium Pharmaceutical (COLL) in Q3 2025, closing a stake of 17,307 shares — an estimated $512K sold.

First Trust Advisors first reported a position in COLL in Q3 2021 and held it in 13 quarters. The position peaked at $5.46M in Q3 2024. 244 funds tracked by Wall St. Rank hold COLL as of Q3 2025.

  • First Trust Advisors reported no remaining Collegium Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • First Trust Advisors sold 17,307 Collegium Pharmaceutical shares in Q3 2025, an estimated $512K.
  • First Trust Advisors first reported a position in Collegium Pharmaceutical in Q3 2021 and held it in 13 quarters.
  • First Trust Advisors's Collegium Pharmaceutical position peaked at $5.46M in Q3 2024.
  • 244 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2025.

Based on First Trust Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.